Management of Hyperthyroidism in Graves' Disease

Adjunctive Therapy

The American Academy of Family Physicians recommends adding a beta-blocker (propranolol or atenolol 25-50 mg daily) for symptomatic relief during the first 2-4 weeks until thyroid hormone levels normalize 1, 2, 3
Beta-blockers should be titrated to maintain heart rate <90 bpm if blood pressure allows, as suggested by the Journal for ImmunoTherapy of Cancer 1

The American Academy of Family Physicians advises monitoring for agranulocytosis, which typically presents with sore throat and fever, and obtaining a complete blood count immediately if these symptoms develop 3

In pregnancy, the American Academy of Family Physicians recommends using the lowest possible dose that maintains Free T4 in the high-normal range, and monitoring Free T4 or Free T4 Index every 2-4 weeks 3

For grade 3-4 hyperthyroidism, the Journal for ImmunoTherapy of Cancer and the Journal of Clinical Oncology suggest holding immune checkpoint inhibitors if applicable, hospitalizing the patient, and obtaining endocrine consultation 1, 2
The Journal for ImmunoTherapy of Cancer and the Journal of Clinical Oncology recommend providing aggressive beta-blockade, hydration, and supportive care for severe or life-threatening hyperthyroidism 1, 2
The Journal of Clinical Oncology suggests considering additional therapies including steroids, SSKI (saturated solution of potassium iodide), or higher-dose thionamides as directed by endocrinology 2

The American College of Physicians recommends checking TSH and Free T4 every 2-4 weeks after initiating therapy until euthyroidism is achieved, with consideration of adding T3 measurements for highly symptomatic patients with minimal FT4 elevations 4
After achieving euthyroidism, monitor thyroid function every 4-6 weeks initially, and once stable, extend monitoring intervals to every 3 months during maintenance therapy, watching for transition to hypothyroidism which requires dose adjustment 4
The primary goal is maintaining Free T4 or Free T4 Index in the high-normal range using the lowest possible methimazole dosage, with a target range of 0.8-1.6 ng/dL 4
In pregnancy, measure Free T4 or Free T4 Index every 2-4 weeks and use the lowest possible dose that maintains Free T4 in the high-normal range 4
For patients with severe or life-threatening symptoms, consider hospitalization and add beta-blockers for symptomatic relief, provide hydration and supportive care, and consider endocrine consultation for additional therapies 5
Monitor for adverse effects, including cutaneous reactions, and watch for hypothyroidism, with elevated TSH occurring during recovery phase of thyroiditis, and consider monitoring for 3-4 weeks before treating 5